Search research articles
Contact Us
Filters
Showing results (41-50 of 247) with videos related to
Page
of 25
Sort By:
Virology
|
October 12, 2011
Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus
Liqun Zhang, Peter L Collins, Robert A Lamb, et al.
Journal of Virology
|
October 17, 2006
Nonsegmented negative-strand viruses as vaccine vectors
Alexander Bukreyev, Mario H Skiadopoulos, Brian R Murphy, et al.
Journal of Virology
|
November 16, 2012
p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly
Jens Fricke, Lily Y Koo, Charles R Brown, et al.
Journal of Virology
|
December 14, 2012
Respiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature-sensitive, live-attenuated vaccine candidate that is phenotypically stable at physiological temperature
Cindy Luongo, Christine C Winter, Peter L Collins, et al.
Journal of Virology
|
March 23, 2007
Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro
Stéphane Biacchesi, Brian R Murphy, Peter L Collins, et al.
Expert Review of Vaccines
|
December 22, 2006
Live vaccines for human metapneumovirus designed by reverse genetics
Ursula J Buchholz, Kunio Nagashima, Brian R Murphy, et al.
Virus Research
|
April 4, 2009
Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/Wakuya/20/78
Anandan Paldurai, Madhuri Subbiah, Sachin Kumar, et al.
Journal of Virology
|
May 14, 2004
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV
Teresa R Johnson, Michael N Teng, Peter L Collins, et al.
Journal of Virological Methods
|
January 11, 2007
An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trials
Sonja R Surman, Peter L Collins, Brian R Murphy, et al.
World Journal of Gastroenterology
|
November 1, 2012
Molecular targets in the treatment of alcoholic hepatitis
Ashwin D Dhanda, Richard Wl Lee, Peter L Collins, et al.
Page
of 25
Search research articles
Search
Showing results (41-50 of 247) with videos related to
Sort By:
Page
of 25
Virology
|
October 12, 2011
Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus
Liqun Zhang, Peter L Collins, Robert A Lamb, et al.
Journal of Virology
|
October 17, 2006
Nonsegmented negative-strand viruses as vaccine vectors
Alexander Bukreyev, Mario H Skiadopoulos, Brian R Murphy, et al.
Journal of Virology
|
November 16, 2012
p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly
Jens Fricke, Lily Y Koo, Charles R Brown, et al.
Journal of Virology
|
December 14, 2012
Respiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature-sensitive, live-attenuated vaccine candidate that is phenotypically stable at physiological temperature
Cindy Luongo, Christine C Winter, Peter L Collins, et al.
Journal of Virology
|
March 23, 2007
Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro
Stéphane Biacchesi, Brian R Murphy, Peter L Collins, et al.
Expert Review of Vaccines
|
December 22, 2006
Live vaccines for human metapneumovirus designed by reverse genetics
Ursula J Buchholz, Kunio Nagashima, Brian R Murphy, et al.
Virus Research
|
April 4, 2009
Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/Wakuya/20/78
Anandan Paldurai, Madhuri Subbiah, Sachin Kumar, et al.
Journal of Virology
|
May 14, 2004
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV
Teresa R Johnson, Michael N Teng, Peter L Collins, et al.
Journal of Virological Methods
|
January 11, 2007
An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trials
Sonja R Surman, Peter L Collins, Brian R Murphy, et al.
World Journal of Gastroenterology
|
November 1, 2012
Molecular targets in the treatment of alcoholic hepatitis
Ashwin D Dhanda, Richard Wl Lee, Peter L Collins, et al.
Page
of 25